Maximilian J. Hochmair - Researcher Profile

Publications

3 shown

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn , Aaron S. Mansfield , Aleksandra Szczęsna +18 more

The addition of atezolizumab to chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer resulted in significantly longer overall survival and progress...

2018 New England Journal of Medicine 3263 citations

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi , Delvys Rodríguez‐Abreu , Shirish M. Gadgeel +26 more

In patients with previously untreated metastatic nonsquamous NSCLC without EGFR or ALK mutations, the addition of pembrolizumab to standard chemotherapy of pemetrexed and a plat...

2018 New England Journal of Medicine 6245 citations

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares , Mikhail Dvorkin , Yuanbin Chen +97 more

2019 The Lancet 2014 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 4
Citations: 13,536
Institution: Otto Wagner Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8673-2450

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.